Publication Name	World Journal of Hepatology
Manuscript ID	40404
Country	France

Received	2018-06-21 03:11
Peer-Review Started	2018-06-21 08:43
To Make the First Decision	2018-07-09 08:06
Return for Revision	2018-07-11 01:49
Revised	2018-07-17 14:55
Second Decision	2018-08-02 12:04
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-08-04 19:34
Articles in Press	2018-08-04 19:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-10-23 00:21
Publish the Manuscript Online	2018-10-27 04:40

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift
Manuscript Source	Invited Manuscript
All Author List	Véronique Loustaud-Ratti, Marilyne Debette-Gratien and Paul Carrier
ORCID	Author(s) ORCID Number Véronique Loustaud-Ratti http://orcid.org/0000-0002-6951-0784 Marilyne Debette-Gratien http://orcid.org/0000-0001-6039-1355 Paul Carrier http://orcid.org/0000-0001-9750-2506
Funding Agency and Grant Number
Corresponding Author	Véronique Loustaud-Ratti, MD, Professor, Fédération d’hépatologie, Service d’Hépato-gastroentérologie, CHU Limoges, 2, Avenue Martin Luther King, Limoges 87042, France. veronique.loustaud-ratti@unilim.fr
Key Words	French; European; Hepatitis C; Guidelines; Pangenotypic; Direct acting antiviral drugs; Eradication; People who inject drugs; Migrants
Core Tip	New French and European guidelines for the management of hepatitis C virus infection take into account the rapid change in the epidemiology of the infection and the arrival of short treatments, based on pangenotypic drugs with very few side effects. However, the French guidelines have a strong bias towards viral eradication with the elaboration of a simplified pathway for patients who are far from traditional healthcare struc­tures.
Publish Date	2018-10-27 04:40
Citation	Loustaud-Ratti V, Debette-Gratien M, Carrier P. European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift. World J Hepatol 2018; 10(10): 639-644
URL	http://www.wjgnet.com/1948-5182/full/v10/i10/639.htm
DOI	http://dx.doi.org/10.4254/wjh.v10.i10.639

Full Article (PDF)	WJH-10-639.pdf
Full Article (Word)	WJH-10-639.doc
Manuscript File	40404-Review.docx
Answering Reviewers	40404-Answering reviewers.pdf
Audio Core Tip	40404-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	40404-Conflict-of-interest statement.pdf
Copyright License Agreement	40404-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	40404-Language certificate.pdf
Peer-review Report	40404-Peer-review(s).pdf
Scientific Misconduct Check	40404-Scientific misconduct check.pdf
Scientific Editor Work List	40404-Scientific editor work list.pdf